Research use only · Not for human or animal consumption · Qualified purchasers only

Velour Research.
Back to catalog
KLOW research material vial
lot VRL-KLW-2601
Each component ≥99% HPLC · RUO

Tissue pathway research

KLOW

BPC-157 + GHK-Cu + TB-500 + KPV

Four-peptide research stack · barrier, matrix, and peptide pathway studies

An 80 mg multi-peptide research stack combining BPC-157 10 mg, GHK-Cu 50 mg, TB-500 10 mg, and KPV 10 mg in one vial, positioned for investigators studying overlapping matrix biology, fibroblast, barrier, and inflammatory signaling pathways.


For laboratory research use only. Not for human or animal consumption, not a drug, food, cosmetic, or supplement. By adding to cart, the researcher affirms compliance with all applicable regulations.

Selected research material

KLOW

80mg vial · SKU VRL-KLW-80

Lot VRL-KLW-2601Each component ≥99% HPLC

Choose vial size

COA record

VRL-KLW-2601

Secure checkout

Waave

Fulfillment

Cold-chain

Research price

$139

RUO only · Lot-matched documentation · Cold-chain handling

Specifications

Molecular formula
Composite blend of BPC-157, GHK-Cu, TB-500, and KPV
Molecular weight
7272.48 g/mol
Sequence
BPC-157 (15 aa) · GHK-Cu tripeptide complex · TB-500 fragment · KPV tripeptide
Purity (HPLC)
Each component ≥99%
Appearance
Lyophilized peptide blend
Storage
Store lyophilized at −20 °C, protected from light and moisture
Reconstitution
Reconstitute in sterile diluent appropriate to researcher protocol
Latest lot
VRL-KLW-2601
Open COA record

KLOW is a four-component research stack built for investigators who want one vial spanning connective tissue pathway research, fibroblast signaling, extracellular matrix remodeling, and barrier-response pathway work. It combines BPC-157, GHK-Cu, TB-500, and KPV into a single internal reference stack.

Across the underlying literature, BPC-157 has been examined in tendon, ligament, gut, and angiogenic models; GHK-Cu has been studied in fibroblast activation, collagen signaling, and dermal remodeling; Thymosin β4 / TB-500 has been explored in migration and wound-repair models; and KPV has been investigated in inflammatory signaling and epithelial barrier contexts.

Supplied as a research-use-only stack for pathway-combination studies and internal formulation work. Not supplied for human or veterinary use.